Arovella Therapeutics Ltd Sustainability Reports
Arovella Therapeutics Limited is a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform to treat blood cancers and solid tumors.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 213800ZLEGQO7S9FNV29
9 reports from 2022 to 2026
